Medio Labs

About Medio Labs

Medio Labs offers a diagnostic platform, MedioSeq, that enables clinical laboratories to perform pathogen diagnostics, replacing traditional qPCR methods. This technology allows for more efficient and potentially comprehensive molecular testing in CLIA/CAP-certified labs.

<problem> Traditional pathogen diagnostics in clinical laboratories often rely on qPCR methods, which can be inefficient and limited in scope for comprehensive molecular testing. This can lead to slower turnaround times and potentially miss less common pathogens. </problem> <solution> Medio Labs offers MedioSeq, a diagnostic platform designed to enable clinical laboratories to perform more efficient and comprehensive pathogen diagnostics, replacing traditional qPCR methods. MedioSeq leverages advanced sequencing technology to identify a wide range of pathogens in a single assay, improving the speed and accuracy of diagnosis. The platform is designed for seamless integration into CLIA/CAP-certified labs, providing a streamlined workflow for molecular testing. By offering a more comprehensive and efficient approach to pathogen detection, MedioSeq aims to improve patient outcomes and reduce healthcare costs. </solution> <features> - Advanced sequencing technology for broad pathogen detection - Streamlined workflow for CLIA/CAP-certified labs - Single assay for multiple pathogen identification - Improved speed and accuracy compared to traditional qPCR methods </features> <target_audience> The primary customers are clinical laboratories seeking to improve the efficiency and comprehensiveness of their pathogen diagnostics. </target_audience>

What does Medio Labs do?

Medio Labs offers a diagnostic platform, MedioSeq, that enables clinical laboratories to perform pathogen diagnostics, replacing traditional qPCR methods. This technology allows for more efficient and potentially comprehensive molecular testing in CLIA/CAP-certified labs.

Where is Medio Labs located?

Medio Labs is based in Emeryville, United States.

When was Medio Labs founded?

Medio Labs was founded in 2020.

Location
Emeryville, United States
Founded
2020
Employees
4 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

Start Searching

Medio Labs

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

Medio Labs offers a diagnostic platform, MedioSeq, that enables clinical laboratories to perform pathogen diagnostics, replacing traditional qPCR methods. This technology allows for more efficient and potentially comprehensive molecular testing in CLIA/CAP-certified labs.

medio.ai500+
Founded 2020 – Emeryville, United States

Funding

No funding information available.

Team (<5)

No team information available.

Company Description

Problem

Traditional pathogen diagnostics in clinical laboratories often rely on qPCR methods, which can be inefficient and limited in scope for comprehensive molecular testing. This can lead to slower turnaround times and potentially miss less common pathogens.

Solution

Medio Labs offers MedioSeq, a diagnostic platform designed to enable clinical laboratories to perform more efficient and comprehensive pathogen diagnostics, replacing traditional qPCR methods. MedioSeq leverages advanced sequencing technology to identify a wide range of pathogens in a single assay, improving the speed and accuracy of diagnosis. The platform is designed for seamless integration into CLIA/CAP-certified labs, providing a streamlined workflow for molecular testing. By offering a more comprehensive and efficient approach to pathogen detection, MedioSeq aims to improve patient outcomes and reduce healthcare costs.

Features

Advanced sequencing technology for broad pathogen detection

Streamlined workflow for CLIA/CAP-certified labs

Single assay for multiple pathogen identification

Improved speed and accuracy compared to traditional qPCR methods

Target Audience

The primary customers are clinical laboratories seeking to improve the efficiency and comprehensiveness of their pathogen diagnostics.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.